scholarly article | Q13442814 |
P50 | author | Carl Latkin | Q64481885 |
Oluwaseun Falade-Nwulia | Q82728624 | ||
Shruti H Mehta | Q85470954 | ||
Alexander Niculescu | Q87219036 | ||
David L Thomas | Q89653947 | ||
Mark Sulkowski | Q89653950 | ||
P2093 | author name string | K R Page | |
C O'Connor | |||
P Chaulk | |||
J Lasola | |||
K Ghanem | |||
P2860 | cites work | Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II | Q28260514 |
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
Insurance status and treatment candidacy of hepatitis C patients: analysis of population-based data from the United States | Q33819963 | ||
The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis | Q33837518 | ||
Mental and physical symptoms associated with lower social support for patients with hepatitis C. | Q33867829 | ||
Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. | Q34294185 | ||
Barriers to the treatment of hepatitis C. Patient, provider, and system factors | Q34723678 | ||
Changes in blood-borne infection risk among injection drug users | Q34772870 | ||
The costs and impacts of testing for hepatitis C virus antibody in public STD clinics | Q35696958 | ||
Is there an association between alcohol consumption and sexually transmitted diseases? A systematic review | Q36053457 | ||
Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008 | Q36100389 | ||
Concurrent group treatment for hepatitis C: implementation and outcomes in a methadone maintenance treatment program | Q36421892 | ||
Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002. | Q36579571 | ||
The relationship between recent alcohol use and sexual behaviors: gender differences among sexually transmitted disease clinic patients | Q36986655 | ||
Racial differences in hepatitis C treatment eligibility | Q37077462 | ||
Racial disparity in liver disease: Biological, cultural, or socioeconomic factors | Q37095472 | ||
Limited uptake of hepatitis C treatment among injection drug users | Q37238205 | ||
Hepatitis C virus control among persons who inject drugs requires overcoming barriers to care | Q37358615 | ||
The new paradigm of hepatitis C therapy: integration of oral therapies into best practices | Q37455611 | ||
Patients attending STD clinics in an evolving health care environment. Demographics, insurance coverage, preferences for STD services, and STD morbidity | Q38554928 | ||
Screening for chronic hepatitis B and C virus infections in an urban sexually transmitted disease clinic: rationale for integrating services | Q39563257 | ||
Hepatitis C seroprevalence and risk behaviors in patients attending sexually transmitted disease clinics | Q39639028 | ||
Integrating viral hepatitis prevention services into an urban STD clinic: Denver, Colorado | Q39799454 | ||
The continuum of hepatitis C testing and care. | Q40231197 | ||
Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States | Q40786866 | ||
Identification and Linkage to Care of HCV-Infected Persons in Five Health Centers - Philadelphia, Pennsylvania, 2012-2014. | Q40966047 | ||
Hepatitis B and hepatitis C in emergency department patients | Q42069509 | ||
Integrating viral hepatitis prevention into STD clinics in Illinois (excluding Chicago), 1999-2005. | Q42732026 | ||
Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. | Q42988446 | ||
Hepatitis C in the United States | Q42992102 | ||
Significant reductions in drinking following brief alcohol treatment provided in a hepatitis C clinic | Q43120673 | ||
The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. | Q44979610 | ||
Hepatitis C virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and Prevention | Q45355364 | ||
Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases | Q45778719 | ||
AUDIT-C as a brief screen for alcohol misuse in primary care. | Q51756065 | ||
Hepatitis C testing, infection, and linkage to care among racial and ethnic minorities in the United States, 2009-2010 | Q64128181 | ||
P433 | issue | 5 | |
P921 | main subject | hepatitis C | Q154869 |
public health | Q189603 | ||
P304 | page(s) | 366-374 | |
P577 | publication date | 2016-02-03 | |
P1433 | published in | Journal of Viral Hepatitis | Q15749962 |
P1476 | title | Public health clinic-based hepatitis C testing and linkage to care in Baltimore | |
P478 | volume | 23 |
Q98892424 | Accelerating the elimination of hepatitis C in Kuwait: An expert opinion |
Q64897566 | Barriers and facilitators of hepatitis C treatment uptake among people who inject drugs enrolled in opioid treatment programs in Baltimore. |
Q58603844 | Comparison of hepatitis C virus testing recommendations in high-income countries |
Q38613271 | Direct-acting antiviral agents for HCV infection affecting people who inject drugs |
Q40118647 | Directly observed therapy of sofosbuvir/ribavirin +/- peginterferon with minimal monitoring for the treatment of chronic hepatitis C in people with a history of drug use in Chennai, India (C-DOT). |
Q91899720 | Disparities in Hepatitis C Linkage to Care in the Direct Acting Antiviral Era: Findings From a Referral Clinic With an Embedded Nurse Navigator Model |
Q57301030 | Economic Comparison of Serologic and Molecular Screening Strategies for Hepatitis C Virus |
Q64237696 | Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs |
Q90682036 | Hepatitis C Screening: Barriers to Linkage to Care |
Q38961563 | Hepatitis C Treatment and Barriers to Eradication |
Q57166986 | Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework |
Q38906623 | Improving support and education of low-income baby boomers diagnosed with chronic hepatitis C virus infection through universal screening. |
Q90067192 | Individual and network factors associated with HCV treatment uptake among people who inject drugs |
Q64936868 | Leveraging the electronic health record to eliminate hepatitis C: Screening in a large integrated healthcare system. |
Q33717043 | Mitigating the heroin crisis in Baltimore, MD, USA: a cost-benefit analysis of a hypothetical supervised injection facility |
Q56891090 | Monitoring the hepatitis C care cascade using administrative claims data |
Q88780662 | Pay It Forward: Building Capacity to Treat Hepatitis C by Training Our Own Residents |
Q91908431 | Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C-SCOPE Study |
Q98895261 | Persistent Challenges in the Hepatitis C Virus Care Continuum for Patients in a Central Texas Public Health System |
Q37573484 | Primary Care Providers Knowledge, Attitude and Practices Related to Hepatitis C Screening and Treatment in the Oral Direct Acting Antiviral Agents Era. |
Q59352236 | Race and Hepatitis C Care Continuum in an Underserved Birth Cohort |
Q38661825 | Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs |
Q55429477 | Sample-to-Answer Droplet Magnetofluidic Platform for Point-of-Care Hepatitis C Viral Load Quantitation. |
Q36858828 | Strategies for Expanding Access to HBV and HCV Testing and Care in the United States: The CDC Hepatitis Testing and Linkage to Care Initiative, 2012-2014 |
Q64132787 | The Hepatitis C Virus Care Continuum: Linkage to Hepatitis C Virus Care and Treatment Among Patients at an Urban Health Network, Philadelphia, PA |